Shares of Cresco Labs Inc. (OTCMKTS:CRLBF – Get Free Report) have been assigned an average recommendation of “Buy” from the five brokerages that are covering the company, MarketBeat reports. Two investment analysts have rated the stock with a hold rating, one has given a buy rating and two have assigned a strong buy rating to the company. The average 12 month target price among analysts that have covered the stock in the last year is $3.00.
Several equities research analysts have weighed in on the company. Cormark upgraded Cresco Labs from a “hold” rating to a “moderate buy” rating in a research note on Monday, March 17th. Atb Cap Markets cut Cresco Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, December 9th.
Get Our Latest Stock Report on CRLBF
Cresco Labs Trading Down 0.2 %
Cresco Labs (OTCMKTS:CRLBF – Get Free Report) last issued its quarterly earnings results on Friday, March 14th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01). The business had revenue of $176.00 million during the quarter, compared to analysts’ expectations of $172.10 million. Cresco Labs had a negative return on equity of 16.52% and a negative net margin of 9.15%. On average, research analysts predict that Cresco Labs will post -0.2 earnings per share for the current fiscal year.
About Cresco Labs
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
Further Reading
- Five stocks we like better than Cresco Labs
- What is a Special Dividend?
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- What Does a Stock Split Mean?
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- Basic Materials Stocks Investing
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.